Drugs / Sulodexide
Sulodexide
also known as
KRX-101 · KRX-101 (sulodexide) · SLX · Sulodexida · Vessel · Vessel due f · Vessel due F (Alfasgima SpA, Italy)
Trials 13 · a red edge is where a trial was stopped
Also used as a comparator or background therapy in 6 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT02737670 Comparator | Aug 2014 → Mar 2017 | tinnitus | St Joseph University, Beirut, Lebanon | Completed | No outcome recorded |
| Phase 2 | NCT01295775 Comparator | Feb 2009 → Apr 2011 | background diabetic retinopathy | Ajou University School of Medicine | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT04483830 Comparator | Jun → Aug 2020 | COVID-19 | Clinedem | Completed | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT05371925 Comparator | Jun 2023 → Feb 2024 | post-COVID-19 disorder, thrombotic disease | Centro Medico del Noroeste | Completed | No outcome recorded |
| Phase 3 | NCT04257487 Comparator | Dec 2020 → Dec 2025 overdue | venous thromboembolism | Arianna Anticoagulazione Foundation | Recruiting | No outcome recorded |
| Phase 3 | NCT01000545 Comparator | Nov 2009 → Jan 2011 | chronic kidney disease | Corbridge Group Philippines, Inc. | Unknown | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 21 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sulodexide | “This study compares the efficacy and safety of sulodexide (Vessel) to placebo in patients with chronic venous disease of the lower extremities.” NCT05005052 ↗18“After surgical intervention the active treatment group will receive sulodexide 250 lipasemic units (LSU) bid for 30 days.” NCT04180137 ↗ |
| Known as | KRX-101 | “An Open Label Tolerability and Safety Study of KRX-101 (Sulodexide Gelcaps) for the Treatment of Type 2 Diabetic Nephropathic Patients With Persistent Microalbuminuria in...” NCT00462202 ↗ |
| Known as | KRX-101 (sulodexide) | “KRX-101 (sulodexide)” NCT00583427 ↗ |
| Known as | SLX | “SLX” NCT01000545 ↗ |
| Known as | Sulodexida | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108086 ↗ |
| Known as | Vessel | “This study compares the efficacy and safety of sulodexide (Vessel) to placebo in patients with chronic venous disease of the lower extremities.” NCT05005052 ↗ |
| Known as | Vessel due f | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108086 ↗ |
| Known as | Vessel due F (Alfasgima SpA, Italy) | “Vessel due F (Alfasgima SpA, Italy)” NCT05371925 ↗ |
| Modality | Other / unclassified | “Sulodexide, a heterogenous group of sulfated glycosaminoglycans” PMID 21872376 ↗ Aug 2011 |
| Route | Oral | “administered orally twice a day.” NCT00130208 ↗ |